Number of Current Board & Advisor Roles 5
Number of Founded Organizations 1
  • Investor Type  Investment Partner

Jesse I. Treu is the Board Member at Veracyte Inc.

Dr. Treu has been a Partner of Domain since its inception in 1985. He has been a director of more than 30 early-stage healthcare companies, 18 of which have so far become successful public companies.

At present, his board memberships include

Afferent Pharmaceuticals,

CoLucid

Pharmaceuticals,

Regado Biosciences,

Tandem Diabetes Care and

Veracyte.

He has served as a Founder, President and Chairman of numerous venture stage companies.

Prior to the formation of Domain, Dr. Treu was vice president of the predecessor organization to The Wilkerson Group, and its venture capital arm, CW Ventures. While at CW Ventures, he served as President and CEO of Microsonics, a pioneer in computer image processing for cardiology.

Prior to that, Dr. Treu held executive positions at Technicon Instruments Corporation (now Siemens Medical Solutions Diagnostics), and at GE.

Education:

B.S. - Rensselaer Polytechnic Institute, 1968

M.A. & Ph.D. - Princeton University, 1971, 1973

Number of Current Jobs 3
Number of Past Jobs 1
Jesse I. Treu has 3 current jobs including Chairman & CEO at Stellar Energy Foundation, Founding Partner at Domain Associates, and Global Citizenship Investment worldwide at Indian Real Estate Forum. Additionally, Jesse I. Treu has had 1 past job as the Presidnet at CW Ventures.
Organization Name  
Title At Company  
Start Date  
End Date  
CW Ventures
Presidnet
Number of Current Board & Advisor Roles 5
Jesse I. Treu holds 5 board and advisor roles including Board of Director at CoLucid Pharmaceuticals, Board of Directors at Tandem Diabetes Care, and Board of Director at Afferent Pharmaceuticals.
Number of News Articles 1
NewsJul 9, 2015